David Jakob Lemus's most recent trade in Silence Therapeutics Plc - ADR was a trade of 48,000 Share Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Silence Therapeutics Plc -... | David Jakob Lemus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 48,000 | 48,000 | - | - | Share Option (Right to Buy) | |
| Scilex Holding Company | David Jakob Lemus | Director | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 17 Oct 2024 | 2,000 | 2,000 | - | 0.9 | 1,800 | Common Stock |
| Scilex Holding Company | David Jakob Lemus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 100,000 | 100,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Scilex Holding Company | David Jakob Lemus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,000 | 250,000 | - | - | Nonstatutory Stock Option (right to buy) |